Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.1 (chymotrypsin)
 10,938 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An acrosin inhibitor was isolated from bull seminal plasma by gel filtration on Sephadex G-50 fine and ion-exchange chromatography on CM-Sephadex. The inhibitor is a basic polypeptide (pl greater than or equal to 10.5) of molecular weight 6 200 (calculated from amino acid composition). Its N-terminal amino group is blocked. The inhibitor is not strictly specific in its effect since it also inhibits trypsin and to a lesser degree chymotrypsin, in addition to bull and boar acrosin.
 ...
PMID:Isolation of basic acrosin inhibitor from bull seminal plasma (BUSI II). 39 4

Acidic extracts of washed, ejaculated human spermatozoa contain, besides acrosin, two proteinase inhibitors, a trypsin-chymotrypsin (elastase) inhibitor (HUSI-I) and a trypsin-acrosin inhibitor (HUSI-II). Using the indirect immunofluorescence technique these inhibitors could be localized in the spermatozoa. Ejaculated spermatozoa were treated with monospecific antibodies raised in rabbits against HUSI-I and HUSI-II, respectively, and with fluorescein-labeled IgG from goat directed against the rabbit IgG. If acetone-fixed spermatozoa were used, fluorescence appeared only in a small ring near or at the equatorial segment of the spermatozoa. After prefixation of washed spermatozoa with 0.36% formaldehyde, however, distribution of both inhibitors in the region of the acrosomal caps could clearly be demonstrated. Present results suggest that they are attached at the plasma membrane. Obviously, in the case of human spermatozoa the inhibitors are relatively easily detached together with the membrane so that prefixation is necessary to achieve proper localization.
 ...
PMID:Localization of seminal plasma proteinase inhibitors in human spermatozoa as revealed by the indirect immunofluorescence technique. 79 87

Using immunoaffinity chromatography on a Sepharose 4B column with adsorbed antibodies to the basic inhibitor in bovine organs (Kunitz-type), a proteinase inhibitor was isolated from boar seminal vesicle fluid. The isolated protein inhibited acrosin, trypsin, plasmin and chymotrypsin, but not kallikrein. Its molecular weight determined by gel filtration on Sephadex G-50 was 9,500 (+/- 500) and by SDS electrophoresis in polyacrylamide gel 12,000 (+/- 500) daltons. The protein was demonstrated by immunoprecipitation only in boar seminal vesicle fluid and seminal plasma, and by indirect immunofluorescence on ejaculated spermatozoa and in the epithelium of boar seminal vesicles. This inhibitor is the first acrosin inhibitor specific for the genital organs, which evidently belongs to the group of Kunitz type inhibitors, to be described.
 ...
PMID:A Kunitz type of proteinase inhibitor isolated from boar seminal vesicle fluid. 293 36

A new anionic acrosin inhibitor was found in an acidic extract of boar spermatozoa. The protein was purified by hydrophobic and ion exchange chromatography. According to gel filtration and SDS-electrophoresis the inhibitor preparation shows a molecular mass of Mr approximately 6000-7000 daltons. The isoelectric point is close to pH 4.5. It is an effective inhibitor of boar acrosin and bovine trypsin, but it does not inhibit porcine plasmin and pancreatic kallikrein or bovine chymotrypsin. An inhibitor with identical properties was found in high concentration (97% of the total acrosin inhibiting activity) in the fluid of cauda epididymis and also as a minor acrosin inhibiting component (2% of total acrosin inhibiting activity) in seminal plasma. The results indicate that binding of the inhibitor to spermatozoa may have taken place in the epididymis.
 ...
PMID:Demonstration of an anionic acrosin inhibitor in spermatozoa epididymal fluid and seminal plasma of the boar. 390 26

Kallikrein-related peptidases (KLKs) play a central role in skin desquamation. They are tightly controlled by specific inhibitors, including the lymphoepithelial Kazal-type inhibitor (LEKTI) encoded by SPINK5 and LEKTI-2 encoded by SPINK9. Herein, we identify SPINK6 as a selective inhibitor of KLKs in the skin. Unlike LEKTI but similar to LEKTI-2, SPINK6 possesses only one typical Kazal domain. Its mRNA was detected to be expressed at low levels in several tissues and was induced during keratinocyte differentiation. Natural SPINK6 was purified from human plantar stratum corneum extracts. Immunohistochemical analyses revealed SPINK6 expression in the stratum granulosum of human skin at various anatomical localizations and in the skin appendages, including sebaceous glands and sweat glands. SPINK6 expression was decreased in lesions of atopic dermatitis. Using KLK5, KLK7, KLK8, KLK14, thrombin, trypsin, plasmin, matriptase, prostasin, mast cell chymase, cathepsin G, neutrophil elastase, and chymotrypsin, inhibition with recombinant SPINK6 was detected only for KLK5, KLK7, and KLK14, with apparent K(i) values of 1.33, 1070, and 0.5 nm, respectively. SPINK6 inhibited desquamation of human plantar callus in an ex vivo model. Our findings suggest that SPINK6 plays a role in modulating the activity of KLKs in human skin. A selective inhibition of KLKs by SPINK6 might have therapeutic potential when KLK activity is elevated.
 ...
PMID:Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. 2066 19